Abstract
Introduction
Primary brain malignancies (PBMs) pose significant morbidity and poor prognosis. Despite NCCN recommendations that palliative care should be integrated into general oncologic care plans, it has been historically underused in patients with PBM. We sought to examine trends and factors associated with inpatient palliative care use in patients with PBM.
Methods
Data from the 2007–2016 National (Nationwide) Inpatient Sample was analyzed for descriptive statistics and trends. Multivariable logistic regression was used to identify factors associated with inpatient palliative care in patients with PBMs.
Results
Of the 510,238 observed hospitalizations of adults with PBM in a 10-year period, 37,365 (7.3%) had an associated inpatient palliative care consult. Rates of inpatient palliative care have increased significantly over the 10-year period, from 2.3 in 2007 to 11.9% in 2011. Patients receiving inpatient palliative care were less likely to receive inpatient oncologic treatment such as brain surgery, chemotherapy, or radiation compared to those without palliative care (14.6% with palliative care vs. 42.4% without, p < 0.001). They were more likely to receive life-sustaining treatments such as intubation, mechanical ventilation, tracheostomy, nutritional support, hemodialysis, or CPR (21.0% with palliative care vs. 10.4% without, p < 0.001). Palliative care was associated with decreased cost of admission ($18,602 with palliative care vs. $20,077 without). In a multiple variable logistic regression, age, non-elective admission, comorbidities, history of chemotherapy and radiation, and mechanical ventilation were associated with significantly increased odds of receiving palliative care.
Conclusions
Inpatient palliative care utilization for patients hospitalized with PBM significantly increased between 2007 and 2016, though the service is still underutilized in the context of the severe symptoms and poor prognosis associated with PBM.
Similar content being viewed by others
Data availability
This National Inpatient Sample (NIS) dataset is available through the Healthcare Cost and Utilization Project from the Agency for Healthcare Research and Quality.
Code availability
The code generated during the current study is available from the corresponding author upon reasonable request.
References
Gofton TE, Graber J, Carver A (2012) Identifying the palliative care needs of patients living with cerebral tumors and metastases: a retrospective analysis. J Neurooncol 108(3):527–534. https://doi.org/10.1007/s11060-012-0855-y
Walbert T (2014) Integration of palliative care into the neuro-oncology practice: patterns in the United States. Neuro-Oncology Pract 1(1):3–7. https://doi.org/10.1093/nop/npt004
Lapointe S, Perry A, Butowski NA (2018) Primary brain tumours in adults. Lancet 392(10145):432–446. https://doi.org/10.1016/S0140-6736(18)30990-5
National Comprehensive Cancer Network (2021) Palliative care (version 2.2021). Retrieved from https://www.nccn.org/professionals/physician_gls/pdf/palliative.pdf
Rubens M, Ramamoorthy V, Saxena A et al (2019) Palliative care consultation trends among hospitalized patients with advanced cancer in the United States, 2005 to 2014. Am J Hosp Palliat Med 36(4):294–301. https://doi.org/10.1177/1049909118809975
Pace A, Di Lorenzo C, Capon A et al (2012) Quality of care and rehospitalization rate in the last stage of disease in brain tumor patients assisted at home: a cost effectiveness study. J Palliat Med 15(2):225–227. https://doi.org/10.1089/jpm.2011.0306
Lin E, Rosenthal MA, Le BH, Eastman P (2012) Neuro-oncology and palliative care: a challenging interface. Neuro Oncol 14(SUPPL.4):3. https://doi.org/10.1093/neuonc/nos209
HCUP-US NIS Overview. https://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed October 28, 2020.
Mulvey CL, Smith TJ, Gourin CG (2016) Use of inpatient palliative care services in patients with metastatic incurable head and neck cancer. Head Neck 38(3):355–363. https://doi.org/10.1002/hed.23895
Hwang J, Shen J, Kim SJ et al (2019) Ten-year trends of utilization of palliative care services and life-sustaining treatments and hospital costs associated with patients with terminally Ill lung cancer in the United States from 2005 to 2014. Am J Hosp Palliat Med 36(12):1105–1113. https://doi.org/10.1177/1049909119852082
Shen JJ, Ko E, Kim P et al (2018) Life-sustaining procedures, palliative care consultation, and do-not resuscitate status in dying patients with COPD in US hospitals: 2010–2014. J Palliat Care 33(3):159–166. https://doi.org/10.1177/0825859718777375
Khera R, Angraal S, Couch T et al (2017) Adherence to methodological standards in research using the National Inpatient Sample. JAMA - J Am Med Assoc 318(20):2011–2018. https://doi.org/10.1001/jama.2017.17653
Di Luca DG, Feldman M, Jimsheleishvili S et al (2020) Trends of inpatient palliative care use among hospitalized patients with Parkinson’s disease. Park Relat Disord 77:13–17. https://doi.org/10.1016/j.parkreldis.2020.06.011
Dumanovsky T, Augustin R, Rogers M, Lettang K, Meier DE, Morrison RS (2016) The growth of palliative care in U.S. Hospitals: a status report. J Palliat Med. 19(1):8–15. https://doi.org/10.1089/jpm.2015.0351
Kamal AH, Bull JH, Swetz KM, Wolf SP, Shanafelt TD, Myers ER (2017) Future of the palliative care workforce: preview to an impending crisis. Am J Med 130(2):113–114. https://doi.org/10.1016/j.amjmed.2016.08.046
Vierhout M, Daniels M, Mazzotta P, Vlahos J, Mason WP, Bernstein M (2017) The views of patients with brain cancer about palliative care: a qualitative study. Curr Oncol 24(6):374–382. https://doi.org/10.3747/co.24.3712
Habibi A, Wu SP, Gorovets D et al (2018) Early palliative care for patients with brain metastases decreases inpatient admissions and need for imaging studies. Am J Hosp Palliat Med 35(8):1069–1075. https://doi.org/10.1177/1049909118765405
Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non–small-cell lung cancer. N Engl J Med 363(8):733–742. https://doi.org/10.1056/nejmoa1000678
Mistry NA, Raza SJ, Siddiqui SA (2020) Analysis of inpatient palliative care consultations for patients with metastatic prostate cancer. Am J Hosp Palliat Med 37(2):136–141. https://doi.org/10.1177/1049909119864576
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Sindhu Kubendran and Sharad Goyal. The first draft of the manuscript was written by Sindhu Kubendran and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
The NIS dataset is a de-identified database and does not directly involve “human subjects” per federal regulations and guidance. The NIS dataset does not require Institutional Review Board (IRB) approval or exempt determination. All procedures performed in the study were in accordance with the ethical standards of the institutional and national research committee as well as with the 1964 Helsinki declaration and its later amendments.
Consent to participate
Not applicable.
Consent to publication
All authors consent for publication.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kubendran, S., Schockett, E., Jackson, E. et al. Trends in inpatient palliative care use for primary brain malignancies. Support Care Cancer 29, 6625–6632 (2021). https://doi.org/10.1007/s00520-021-06255-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-021-06255-0